HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Moo-Ho Won Selected Research

platycoside E

7/2009Platycodin D and 2''-O-acetyl-polygalacin D2 isolated from Platycodon grandiflorum protect ischemia/reperfusion injury in the gerbil hippocampus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Moo-Ho Won Research Topics

Disease

146Ischemia
05/2022 - 08/2006
70Transient Ischemic Attack
10/2019 - 07/2008
46Brain Ischemia (Cerebral Ischemia)
09/2021 - 11/2008
24Gliosis
01/2021 - 07/2008
23Reperfusion Injury
04/2022 - 07/2009
22Inflammation (Inflammations)
02/2022 - 11/2008
14Ischemic Stroke
01/2022 - 11/2008
13Heart Arrest (Cardiac Arrest)
01/2022 - 06/2014
13Cognitive Dysfunction
01/2022 - 01/2016
10Type 2 Diabetes Mellitus (MODY)
09/2017 - 03/2009
9Brain Injuries (Brain Injury)
04/2022 - 12/2016
9Hypoxia (Hypoxemia)
01/2018 - 08/2006
8Hypothermia
01/2022 - 07/2019
8Body Weight (Weight, Body)
12/2018 - 03/2009
6Hyperthermia
01/2022 - 01/2015
6Neoplasms (Cancer)
10/2021 - 07/2010
5Vascular Diseases (Vascular Disease)
01/2020 - 08/2012
5Pre-Eclampsia (Preeclampsia)
01/2020 - 01/2017
5Amnesia (Dissociative Amnesia)
04/2018 - 06/2011
5Neurodegenerative Diseases (Neurodegenerative Disease)
04/2018 - 01/2012
4Acidosis
11/2021 - 08/2008
4Atherosclerosis
01/2020 - 03/2013
4Alzheimer Disease (Alzheimer's Disease)
04/2018 - 01/2012
3Epilepsy (Aura)
01/2022 - 01/2018
3Paraplegia (Spastic Paraplegia)
10/2021 - 07/2019
3Spinal Cord Injuries (Spinal Cord Injury)
10/2021 - 01/2012
3Infarction (Infarctions)
01/2019 - 05/2011
3Memory Disorders (Memory Loss)
01/2018 - 12/2009
3Spinal Cord Ischemia
06/2017 - 01/2014
3Neoplasm Metastasis (Metastasis)
02/2017 - 05/2012
3Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2017 - 08/2012

Drug/Important Bio-Agent (IBA)

65Neuroprotective AgentsIBA
04/2022 - 08/2006
62Proteins (Proteins, Gene)FDA Link
09/2021 - 12/2007
54salicylhydroxamic acid (SHAM)IBA
01/2022 - 03/2008
28AntioxidantsIBA
04/2022 - 05/2010
17Glial Fibrillary Acidic ProteinIBA
05/2022 - 02/2008
17cresyl violetIBA
12/2021 - 03/2008
17CalciumIBA
01/2020 - 02/2008
17Brain-Derived Neurotrophic Factor (BDNF)IBA
06/2019 - 06/2010
16CytokinesIBA
11/2021 - 09/2010
13Superoxide DismutaseIBA
04/2022 - 03/2011
13fluoro jadeIBA
12/2021 - 10/2009
12EnzymesIBA
04/2022 - 10/2009
11Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2021 - 09/2009
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2020 - 06/2010
10Superoxide Dismutase-1IBA
01/2020 - 06/2010
9CatalaseIBA
01/2020 - 03/2011
9Glutathione PeroxidaseIBA
01/2020 - 03/2011
9Scopolamine (Hyoscine)FDA Link
04/2018 - 06/2011
7Anticonvulsants (Antiepileptic Drugs)IBA
12/2021 - 12/2015
7MelatoninIBA
10/2019 - 07/2010
7Blood Glucose (Blood Sugar)IBA
12/2018 - 03/2009
6Pharmaceutical PreparationsIBA
01/2022 - 03/2009
6Immunoglobulin G (IgG)IBA
01/2022 - 10/2020
6Interleukin-4 (Interleukin 4)IBA
10/2020 - 09/2010
5Lactic Acid (Lactate)FDA LinkGeneric
11/2021 - 05/2013
5Transcription Factors (Transcription Factor)IBA
07/2021 - 05/2013
5Interleukin-13IBA
10/2020 - 09/2010
5Messenger RNA (mRNA)IBA
01/2019 - 06/2008
4Therapeutic UsesIBA
01/2022 - 12/2019
4Myelin Basic ProteinIBA
12/2021 - 01/2016
4Risperidone (Risperdal Consta)FDA LinkGeneric
10/2021 - 06/2014
4Indicators and Reagents (Reagents)IBA
09/2021 - 06/2010
4Heme Oxygenase-1IBA
04/2021 - 12/2014
4Superoxides (Superoxide)IBA
11/2020 - 01/2011
4MicroRNAs (MicroRNA)IBA
01/2020 - 12/2014
4Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2019 - 05/2014
4Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
12/2018 - 05/2014
4Ethanol (Ethyl Alcohol)IBA
12/2017 - 11/2008
4Nuclear Antigens (Extractable Nuclear Antigens)IBA
06/2017 - 03/2011
4Glucose (Dextrose)FDA LinkGeneric
06/2017 - 05/2016
4ThioredoxinsIBA
01/2017 - 05/2010
4tanshinoneIBA
08/2016 - 09/2013
4CorticosteroneIBA
05/2011 - 05/2010
3Oxcarbazepine (Trileptal)FDA LinkGeneric
12/2021 - 10/2019
3AlbuminsIBA
11/2021 - 01/2012
3Antipsychotic Agents (Antipsychotics)IBA
10/2021 - 06/2014
3Cyclin D1IBA
07/2021 - 07/2010
3decursinIBA
04/2021 - 10/2012
3NMDA receptor A1IBA
01/2021 - 02/2013
3LipidsIBA
05/2020 - 03/2013
3Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
02/2020 - 02/2017
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
02/2020 - 02/2017
3ArginaseIBA
01/2020 - 02/2017
3arginyl-leucyl-tyrosyl-glutamic acidIBA
12/2019 - 02/2017
3Nerve Growth Factors (Neurotrophins)IBA
06/2019 - 06/2012
3fucoidanIBA
01/2019 - 07/2012
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2019 - 11/2008
3Oxygen (Dioxygen)IBA
06/2017 - 01/2014
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2017 - 11/2008
3Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
01/2017 - 08/2012
3Norepinephrine (Noradrenaline)FDA LinkGeneric
11/2016 - 11/2015
3DiterpenesIBA
08/2016 - 12/2012
3InterleukinsIBA
09/2015 - 09/2010
3Malondialdehyde (Propanedial)IBA
05/2015 - 02/2012

Therapy/Procedure

6Induced Hypothermia
01/2022 - 07/2019
6Therapeutics
04/2021 - 09/2014
5Transplantation
01/2018 - 01/2012
4Cardiopulmonary Resuscitation (CPR)
10/2021 - 06/2014
3Aftercare (After-Treatment)
12/2021 - 07/2009